PATIENT SAVINGS & RESOURCES
ONCE-DAILY DOSING FOR ADDED
GLYCEMIC CONTROL1
CYCLOSET® allows you to gradually titrate patients1
CYCLOSET® is available in 0.8-mg tablets for dosing control as you gradually titrate to help patients adjust to therapy and reach their targeted therapeutic effects.1
CYCLOSET® should be taken once daily, with food, within 2 hours of waking.1
If the morning dose is missed, instruct patients to skip the day and take their dose the next morning.1
See More
INDICATION
CYCLOSET® (bromocriptine mesylate) 0.8 mg tablets is a dopamine receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
LIMITATIONS OF USE
- CYCLOSET should not be used to treat type 1 diabetes or diabetic ketoacidosis.
- Limited efficacy data in combination with thiazolidinediones.
- Efficacy has not been confirmed in combination with insulin.
IMPORTANT SAFETY INFORMATION
Contraindications
CYCLOSET is contraindicated in:
- Patients with hypersensitivity to ergot-related drugs, bromocriptine or to any of the excipients in CYCLOSET.
- Patients with syncopal migraines. May precipitate hypotension.
- Postpartum patients. Serious and life-threatening adverse reactions have been reported.
- Lactating patients. CYCLOSET contains bromocriptine which inhibits lactation.
References: 1. CYCLOSET [prescribing information]. Tiverton, RI: VeroScience LLC; 2020. 2. Data on file. Salix Pharmaceuticals.